Magnesium Sulfate Kalceks

Magnesium Sulfate Heptahydrate, the active ingredient in Magnesium Sulfate Kalceks, is an electrolyte supplement presented as an injectable solution for intramuscular, intravenous, or subcutaneous use. It is employed to prevent and treat eclampsia in pregnant women and to correct severe hypomagnesemia.

GNH USA supplies Magnesium Sulfate Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnesium sulfate is used in obstetric and electrolyte‑replacement pathways to manage specific acute conditions.

- Eclampsia: prevents and treats seizures associated with pre‑eclampsia/eclampsia in pregnant patients. - Severe hypomagnesemia: restores normal serum magnesium concentrations in patients with critically low levels. - Torsades de pointes (rarely): may be used as an adjunct to stabilize cardiac rhythm when magnesium deficiency is implicated.

Magnesium sulfate may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Flushing or feeling of warmth. - Sweating. - Nausea or vomiting. - Hypotension. - Injection‑site pain or irritation. - Headache.

Serious or Rare Side Effects: - Respiratory depression or arrest. - Severe hypotension leading to shock. - Cardiac arrhythmias, including bradycardia. - Hypermagnesemia with neuromuscular blockade. - Loss of deep tendon reflexes. - Cardiac arrest.

Magnesium sulfate requires careful monitoring in several clinical situations.

- Renal impairment: monitor serum magnesium and adjust dose. - Cardiac disease: use cautiously; watch for bradycardia and hypotension. - Neuromuscular disorders: increased risk of muscle weakness. - Pregnancy: administer only when maternal benefit outweighs fetal risk. - Concomitant calcium‑containing solutions: avoid simultaneous infusion. - Store below 25°C: keep in original container, protect from moisture.

Magnesium sulfate can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - Calcium‑containing IV solutions: may precipitate and cause embolism. - Aminoglycoside antibiotics: potentiates neuromuscular blockade. - Neuromuscular blocking agents: risk of prolonged paralysis.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may increase risk of hypermagnesemia. - Potassium‑sparing diuretics: monitor electrolyte balance. - Other magnesium‑containing products: avoid cumulative excess.